- Challenging
- Brain Metastasis
Creating a new paradigm for this disease through the development of new personalised cancer therapeutic approaches.
By leveraging new knowledge and understanding brain metastasis’ processes and properties, we aim to challenge the three pillars underlying the poor prognosis of this disease: high lethality, therapeutic resistance and impact in neurocognition and quality of life, for a more rapid development of new diagnostics, treatments, biomarkers, and better approaches in the clinical practice.
Renacer
The Spanish National Network on Brain Metastases (RENACER) consists of a cooperative framework of national reference hospitals, research laboratories and a biobank, which collaborate with each other with the aim of creating a unique collection of human samples and data to promote research on brain metastases, with a view to improving both their diagnosis and treatment.
Through the different complementary and cross-cutting perspectives offered by the RENACER framework, we will advance the development of new, more precise and effective approaches, therapies and personalised treatments. Without RENACER, this work would be almost impossible.
Members & coordinators
RENACER, established at national level, with international vision, is formed by health institutions, basic/translational laboratories and a biobank, which work closely with multidisciplinary groups with diverse backgrounds and expertise, to address the underlying pillars of brain metastasis and its poor prognosis. Learn more about our team on our website.
Results & Achievements
This project aims to disrupt the systemic strategy applied for brain metastases treatment, by leveraging new knowledge and understanding of this disease’s processes and vulnerabilities. Visit our website to learn more about our achievements and ongoing research.
Projects
RENACER, as a national and international reference for researchers and clinicians interested in brain metastases, acts as a critical mass for the organisation of joint research projects, in an ongoing effort to benefit patients. Several initiatives in this regard have been created.
NEWS & EVENTS
Within the project, we aim to achieve significant scientific achievements for the treatment of this metastatic disease; however, no influence or effect will be achieved in the translation of these results, if we are not able to render and communicate the results. For this purpose, we will focus part of our efforts on making the project results visible to a wide audience.
The Spanish Association Against Cancer in Madrid presented the selected AECC Cancer Research Grants 2023, in which the project coordinated by Manuel Valiente was awarded
The Spanish Association Against Cancer and the Association’s Scientific Foundation held on 15 February at the Madrid headquarters, coinciding with International Childhood Cancer Day, the presentation and award ceremony for
CNIO researchers Manuel Valiente, together with Eva Ortega and Fátima Al-Shahrour, received a grant from the CaixaResearch call for Health Research projects, promoted by the «la Caixa» Foundation.
In a ceremony held at the CosmoCaixa Science Museum, the «la Caixa» Foundation presented the grants to the 33 projects from Spain and Portugal selected in the 2023 call. The
FUNDING
